All In Biotech

Free tool

FAERS Monitor: Helium, Usp

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205843 or its brand name (Helium, Usp, Helium). Reports on generic versions are filed under their own applications.

Reports

51

Serious

47

92% of reports

Hospitalization

4

Death reported

33

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • completed suicide23
  • asphyxia6
  • overdose6
  • toxicity to various agents5
  • generalised tonic-clonic seizure4
  • sedation4
  • drug ineffective3
  • drug level increased3
  • myalgia3
  • off label use3
  • abnormal behaviour2
  • aggression2
  • cataplexy2
  • death2
  • depression2

Reports by year received

View as table
YearReports
20051
20071
20133
20147
20159
20163
201711
20182
20198
20201
20212
20221
20241
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cataplexy2583.5149.8653
asphyxiaSignal6303.2143.01,517
completed suicideSignal23113.984.12,470
generalised tonic-clonic seizureSignal499.738.9299
drug level increasedSignal374.824.9151
sedationSignal463.024.6186
abnormal behaviour220.85.421
aggression216.54.216
toxicity to various agentsSignal512.25.341
overdoseSignal611.55.448
myalgiaSignal37.32.411
depression23.60.92
off label use31.40.50
death21.00.20
drug ineffective30.90.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.